We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 1,881

Food & Beverage Litigation Update: Issue 623
  • Shook Hardy & Bacon LLP
  • USA
  • November 18 2016

U.S. Surgeon General Tackles Alcohol Misuse in Addiction Report The U.S. Surgeon General has issued a landmark report intended "to address substance


FDA refuses to re-classify tooth-whitening products as drugs
  • Shook Hardy & Bacon LLP
  • USA
  • May 2 2014

The U.S. Food and Drug Administration (FDA) has denied a Citizen Petition asking the agency to re-categorize tooth-whitening products as drugs


Systematic review summarizes neuropsychological model for obesity
  • Shook Hardy & Bacon LLP
  • USA
  • January 10 2014

A recent systematic review of the current scientific literature "assigning obesity to the spectrum of neuropsychological diseases" has proposed "an


FDA's regulation of trans fats
  • Shook Hardy & Bacon LLP
  • USA
  • January 24 2014

More than 100 years after the advent of artificial trans fats, the U.S. Food and Drug Administration (FDA) has taken the first step toward banning


Prop. 65 lawsuit seeks warnings for acrylamide in coffee
  • Shook Hardy & Bacon LLP
  • USA
  • May 13 2011

The Metzger Law Group has filed a lawsuit under the Safe Drinking Water and Toxic Enforcement Act (Prop. 65) on behalf of the Council for Education and Research on Toxics (CERT), seeking an order to require coffee makers and retailers to warn consumers that coffee contains acrylamide, a chemical known to the state to cause cancer


Landmark Texas Supreme Court decision: learned intermediary doctrine applies in prescription drug cases, no DTC exception
  • Shook Hardy & Bacon LLP
  • USA
  • June 12 2012

Addressing the issue squarely for the first time, the Texas Supreme Court has unanimously adopted the learned intermediary doctrine in the prescription drug context thereby confirming that manufacturers are only obligated to warn doctors of the risks of prescription medicines


Decoding patent-eligibility of diagnostic methods
  • Shook Hardy & Bacon LLP
  • USA
  • May 19 2016

Figuring out whether an invention is patent-worthy has become a bit easier, thanks to the Federal Circuit’s clarifications in Genetic Technologies


Will the Rise of the Machine Mark the Fall of Med Mal?
  • Shook Hardy & Bacon LLP
  • USA
  • June 8 2016

Recently, James Ryan Morales from HealthAim reported on a new study at Children’s National Medical Center in Washington involving the Smart-Tissue


FDA Bans 19 Ingredients from Antibacterial Wash Products
  • Shook Hardy & Bacon LLP
  • USA
  • October 7 2016

The U.S. Food and Drug Administration (FDA) has issued a final rule prohibiting the marketing of over-the-counter consumer antiseptic wash products


Too Much Sugar in Dole Fruit Products, Plaintiff Alleges
  • Shook Hardy & Bacon LLP
  • USA
  • October 21 2016

A consumer has filed a putative class action against Dole Packaged Foods, LLC alleging the company's products contain too much added sugar to be